研究单位：[1]Cancer Institute and Hospital,Chinese Academy of Medical Sciences[2]Tianjin Medical University Cancer Institute and Hospital[3]Anyang Tumor Hospital[4]The First Affiliated Hospital with Nanjing Medical University[5]Affiliated Hospital of Hebei University[6]Fujian Cancer Hospital[7]Sichuan Cancer Hospital and Research Institute[8]Hebei Medical University Fourth Hospital
研究目的：
This phase III trial is designed to explore a higher radiation dose by using IMRT simultaneous integrated boost technique with or without concurrent chemotherapy for esophageal carcinoma with limited lymph node metastasis.
